West Nile Virus Matrix (CT) Blocking Peptide
Referencia W154-50
embalaje : 50µg
Marca : Leinco Technologies
Contact local distributor :
Teléfono : +1 850 650 7790
West Nile Virus Matrix (CT) Blocking Peptide
West Nile Virus Matrix (CT) Blocking Peptide
Product No.: W154
Target West Nile Virus Matrix Protein Product Type Blocking Peptide Alternate Names WNV Matrix Applications IHC FFPE , N , WB |
Antibody DetailsProduct DetailsReactive Species Virus Product Concentration 0.2 mg/ml Amino Acid Location 15 amino acids near the carboxy-terminus of WNV Matrix protein. Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Storage and Handling Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. Background West Nile Virus Matrix Protein peptide is applicable as a control peptide for blocking antibody binding in Western blotting. Antigen DetailsResearch Area Category B Pathogens . Infectious Disease . Viral . West Nile References & Citations1. Yamaguchi K, Shirakabe K, Shibuya H, et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 1995; 270:2008-11. 2. Irie T, Muta T, and Takeshige K. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages. FEBS Lett. 2000; 467:160-4. 3. Akira S and Takeda K. Toll-like receptor Signalling. Nat. Rev. Immunol. 2004; 4:499-511. 4. Jiang Z, Ninomiya-Tsuji J, Qian Y, et al. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell Biol. 2002; 22:7158-67. Technical ProtocolsIHC FFPE N |